首页> 外文期刊>International journal of infectious diseases : >Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine
【24h】

Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine

机译:巴勒斯坦加沙市新生儿重症监护病房的医院多重耐药鲍曼不动杆菌

获取原文
           

摘要

Objectives: We performed a prospective case-control study of bloodstream infections in order to determine the infection rate of Acinetobacter baumannii and to determine the risk factors associated with infection and mortality. Methods: Between February 2004 and January 2005, 579 consecutive blood specimens were collected from the two neonatal intensive care units (NICUs) of Al-Nasser and Al-Shifa hospitals in Gaza City. Results: Forty (6.9%) isolates of A. baumannii were obtained from neonates aged under 28 days. Of the patients, 62.5% were male and 37.5% were female. Compared to matched, uninfected controls, statistically significant risk factors were weight <1500g (odds ratio (OR) 3.89, p<0.001), age <7 days (OR 2.33, p=0.027), median hospitalization of =20 days (OR 3.1, p=0.003), mechanical ventilation (OR 3.5, p=0.001), use of a central venous catheter (CVC; OR 10.5, p<0.001), and prior antibiotic use (OR 4.85, p=0.003). The overall mortality was also significantly different (overall mortality 37.5% in cases vs. 12% in uninfected controls; OR 4.4, p=0.001). Compared to infected controls, statistically significant risk factors were mechanical ventilation (OR 2.68, p=0.008), use of a CVC (OR 6.68, p<0.001), and prior antibiotic use (OR 5.68, p=0.001). The multidrug-resistant type was significantly associated with death in the neonates (p=0.023). The isolates of A. baumannii were resistant to commonly used antibiotics, while susceptible to meropenem (92.5%), imipenem (90%), ciprofloxacin (75%), gentamicin (57.5%), and ceftriaxone (50%). Conclusions: The infection rate with multidrug-resistant A. baumannii is considerable and alarming in NICU infants, and is associated with significant mortality.
机译:目的:我们进行了一项关于血液感染的前瞻性病例对照研究,以确定鲍曼不动杆菌的感染率并确定与感染和死亡相关的危险因素。方法:从2004年2月至2005年1月,从加沙市Al-Nasser和Al-Shifa医院的两个新生儿重症监护病房(NICU)连续采集了579个血液样本。结果:从28岁以下的新生儿中获得了40株(6.9%)鲍曼不动杆菌的分离株。在这些患者中,男性为62.5%,女性为37.5%。与配对的未感染对照相比,统计学上显着的危险因素为体重<1500g(优势比(OR)3.89,p <0.001),年龄<7天(OR 2.33,p = 0.027),中位住院时间为20天(OR 3.1) ,p = 0.003),机械通气(OR 3.5,p = 0.001),使用中央静脉导管(CVC; OR 10.5,p <0.001)和先前使用抗生素(OR 4.85,p = 0.003)。总死亡率也有显着差异(病例总死亡率为37.5%,未感染对照者为12%; OR 4.4,p = 0.001)。与受感染的对照组相比,统计学上显着的危险因素是机械通气(OR 2.68,p = 0.008),使用CVC(OR 6.68,p <0.001)和以前使用抗生素(OR 5.68,p = 0.001)。耐多药型与新生儿死亡显着相关(p = 0.023)。鲍曼不动杆菌的分离株对常用的抗生素具有抗性,同时对美罗培南(92.5%),亚胺培南(90%),环丙沙星(75%),庆大霉素(57.5%)和头孢曲松(50%)敏感。结论:耐多药鲍曼不动杆菌的感染率在新生儿重症监护病房婴儿中相当可观,令人震惊,并与死亡率显着相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号